☆ 4.6 Article

Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis

FRONTIERS IN AGING NEUROSCIENCE (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis

Federico Verde et al.

Summary: This study compared the levels of GFAP in ALS patients and healthy controls and found a moderate correlation between GFAP and age in both groups. ALS patients had higher levels of GFAP, which were not associated with most motor phenotypic features, but were closely related to cognitive scores, eye movement abnormalities, and polysomnographic indices. GFAP was negatively associated with survival and estimated glomerular filtration rate.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

Add to Collection

Article Clinical Neurology

Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis

Eleonora Colombo et al.

Summary: This study aimed to analyze the correlation between electrophysiological parameters and clinical characteristics of ALS. The results showed a significant association between AD and CD scores and disease progression, survival, and functional disability in ALS patients.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Clinical Neurology

Upper motor neuron dysfunction is associated with the presence of behavioural impairment in patients with amyotrophic lateral sclerosis

Alessio Maranzano et al.

Summary: This study found that the burden of upper motor neuron involvement is associated with the presence of behavioral impairment in ALS patients, suggesting a preferential spreading of pathology from the motor cortex to the ventromedial prefrontal and orbitofrontal cortex.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis

Yuri Matteo Falzone et al.

Summary: NfL is a useful biomarker for the diagnosis of ALS and the strongest predictor of survival. UCHL1 is an independent prognostic factor helpful in stratifying survival in patients with low NfL levels, likely to have slowly progressive disease. GFAP reflects extramotor involvement, namely cognitive impairment or frontotemporal dementia.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Amyotrophic lateral sclerosis

Eva L. Feldman et al.

Summary: Amyotrophic lateral sclerosis, a fatal CNS neurodegenerative disease, lacks optimal management strategies. Improved understanding of clinical presentation, pathophysiology, and diagnostic criteria has not yet translated into direct patient benefit. However, the concept of amyotrophic lateral sclerosis as a complex syndrome is already influencing clinical practice.

LANCET (2022)

Add to Collection

Article Medicine, General & Internal

Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

Timothy M. Miller et al.

Summary: This study examined the use of tofersen in patients with SOD1 ALS and found that it can reduce protein concentrations in the cerebrospinal fluid and plasma, but does not improve clinical outcomes and is associated with adverse events. Further investigation is needed to evaluate the effects of early initiation of tofersen.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Clinical Neurology

Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years

Joel Simren et al.

Summary: The recent development of a new method to accurately measure neurofilament light in plasma has revealed its potential as a sensitive and robust biomarker for neuroaxonal damage. Efforts are now being made to incorporate plasma neurofilament light into clinical practice and establish reference values to aid interpretation of test results.

BRAIN COMMUNICATIONS (2022)

Add to Collection

Article Clinical Neurology

Respiratory parameters on diagnostic sleep studies predict survival in patients with amyotrophic lateral sclerosis

Markus Engel et al.

Summary: In ALS patients, EMBE > 2 mmol/l predicts nocturnal hypercapnia and shorter survival. The negative effects of sleep-disordered breathing on survival are eliminated by sustained NIV. EMBE is the only predictor for survival from symptom onset in baseline sleep studies.

JOURNAL OF NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Association of Clinically Evident Eye Movement Abnormalities With Motor and Cognitive Features in Patients With Motor Neuron Disorders

Barbara Poletti et al.

Summary: OMAs are significantly more common in ALS patients compared to cognitively unimpaired controls, especially in those with bulbar onset. The presence of OMAs is strongly correlated with cognitive dysfunction in ALS, suggesting a potential marker of neurodegeneration in the disease.

NEUROLOGY (2021)

Add to Collection

Review Neurosciences

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Federico Verde et al.

Summary: ALS and FTD are currently incurable neurodegenerative diseases lacking specific neurochemical biomarkers, but NFL has shown considerable progress as a biomarker in both diseases, distinguishing them from mimic conditions and providing prognostic information.

FRONTIERS IN NEUROSCIENCE (2021)

Add to Collection

Article Clinical Neurology

Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis

E. Thouvenot et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis

Samir Abu-Rumeileh et al.

JOURNAL OF NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis

Colin Quinn et al.

MUSCLE & NERVE (2020)

Add to Collection

Review Clinical Neurology

Neurofilaments: neurobiological foundations for biomarker applications

Arie R. Gafson et al.

BRAIN (2020)

Add to Collection

Article Clinical Neurology

Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS

Michael Benatar et al.

NEUROLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Renal function is associated with blood neurofilament light chain level in older adults

Shoshin Akamine et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Clinical Neurology

Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis

B. Gille et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)

Add to Collection

Article Clinical Neurology

Assessing anxiety and its correlates in amyotrophic lateral sclerosis: The state-trait anxiety inventory

Mattia Siciliano et al.

MUSCLE & NERVE (2019)

Add to Collection

Review Clinical Neurology

Neurochemical biomarkers in amyotrophic lateral sclerosis

Federico Verde et al.

CURRENT OPINION IN NEUROLOGY (2019)

Add to Collection

Article Clinical Neurology

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

Federico Verde et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Add to Collection

Article Clinical Neurology

Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

Emily Feneberg et al.

NEUROLOGY (2018)

Add to Collection

Review Clinical Neurology

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria

Michael J. Strong et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)

Add to Collection

Article Clinical Neurology

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis Neurofilament Light Chain Levels in Definite Subtypes of Disease

Alessandra Gaiani et al.

JAMA NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients

Petra Steinacker et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Add to Collection

Article Clinical Neurology

Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis

Matthew S. Devine et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2016)

Add to Collection

Article Clinical Neurology

The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS)

Barbara Poletti et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2016)

Add to Collection

Article Clinical Neurology

Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis

Ching-Hua Lu et al.

NEUROLOGY (2015)

Add to Collection

Article Clinical Neurology

Montreal Cognitive Assessment (MoCA)-Italian version: regression based norms and equivalent scores

Silvia Conti et al.

NEUROLOGICAL SCIENCES (2015)

Add to Collection

Article Clinical Neurology

CSF neurofilament light chain reflects corticospinal tract degeneration in ALS

Ricarda A. L. Menke et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)

Add to Collection

Article Clinical Neurology

Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine A Population-Based Study

Adriano Chio et al.

JAMA NEUROLOGY (2014)

Add to Collection

Article Clinical Neurology

A proposed staging system for amyotrophic lateral sclerosis

Jose C. Roche et al.

BRAIN (2012)

Add to Collection

Article Clinical Neurology

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study

Adriano Chio et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)

Add to Collection

Article Medicine, General & Internal

A New Equation to Estimate Glomerular Filtration Rate

Andrew S. Levey et al.

ANNALS OF INTERNAL MEDICINE (2009)

Add to Collection

Review Clinical Neurology

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

C. E. Teunissen et al.

NEUROLOGY (2009)

Add to Collection

Article Clinical Neurology

The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease

A. Alberici et al.

NEUROLOGICAL SCIENCES (2007)

Add to Collection

Article Clinical Neurology

El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis

BR Brooks et al.

AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.